Discontinued — last reported Q4 '23
Total Sleep and Respiratory Care — Operating Income (Loss)
ResMed Total Sleep and Respiratory Care — Operating Income (Loss) remained flat by 0.0% to $375.62M in Q2 2023 compared to the prior quarter. Year-over-year, this metric grew by 14.6%, from $327.89M to $375.62M. Over 2 years (FY 2021 to FY 2023), Total Sleep and Respiratory Care — Operating Income (Loss) shows an upward trend with a 13.3% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
Higher operating income indicates strong pricing power, effective cost management, and operational leverage within the core business segment.
Detailed definition
This metric represents the profitability of the sleep and respiratory care segment after deducting operating expenses fr...
Peer comparison
Comparable to 'Segment Operating Profit' or 'Segment EBIT' reported by diversified medical device peers.
rmd_segment_total_sleep_and_respiratory_care_operating_income_lossHistorical Data
| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | |
|---|---|---|---|---|---|---|---|---|---|
| Value | $406.77M | $327.89M | $327.89M | $327.89M | $327.89M | $375.62M | $375.62M | $375.62M | $375.62M |
| QoQ Change | — | -19.4% | +0.0% | +0.0% | +0.0% | +14.6% | +0.0% | +0.0% | +0.0% |
| YoY Change | — | — | — | — | -19.4% | +14.6% | +14.6% | +14.6% | +14.6% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is ResMed's total sleep and respiratory care — operating income (loss)?
- ResMed (RMD) reported total sleep and respiratory care — operating income (loss) of $375.62M in Q2 2023.
- How has ResMed's total sleep and respiratory care — operating income (loss) changed year-over-year?
- ResMed's total sleep and respiratory care — operating income (loss) increased by 14.6% year-over-year, from $327.89M to $375.62M.
- What is the long-term trend for ResMed's total sleep and respiratory care — operating income (loss)?
- Over 2 years (2021 to 2023), ResMed's total sleep and respiratory care — operating income (loss) has grown at a 13.3% compound annual growth rate (CAGR), from $1.17B to $1.5B.
- What does total sleep and respiratory care — operating income (loss) mean?
- The profit or loss generated by the sleep and respiratory care business before interest and taxes.